A novel image-based high throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease

A novel image-based high throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease

Glycogen storage disorders (GSDs) are caused by excessive accumulation of glycogen. Some GSDs (Adult Polyglucosan Body Disease (APBD), Tarui and Lafora diseases) are caused by intracellular accumulation of insoluble inclusions, called polyglucosan bodies (PB), which are chiefly composed of malconstr...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Solmesky, L, Khazanov, N, Senderowitz, H, Wang, P, Minassian, B, Ferreira, I, Yue, W, Lossos, A, Weil, M, Kakhlon, O
Natura:	Journal article
Lingua:	English
Pubblicazione:	Portland Press 2017

Documenti analoghi

Guaiacol as a drug candidate for treating adult polyglucosan body disease
di: Kakhlon, O, et al.
Pubblicazione: (2018)

Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism
di: Or Kakhlon, et al.
Pubblicazione: (2021-09-01)

Polyglucosan bodies in medullary catecholaminergic neurons in SUDEP
di: Smriti Patodia, et al.
Pubblicazione: (2021-01-01)

Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism
di: Jun Wu, et al.
Pubblicazione: (2024-04-01)

GYG1: A distal myopathy with polyglucosan bodies
di: Stefan Nicolau, et al.
Pubblicazione: (2020-09-01)

First Report on Fetal Cerebral Polyglucosan Bodies in Mucopolysaccharidosis Type VII
di: Hazim Kadhim, et al.
Pubblicazione: (2017-01-01)

Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1
di: Manuel Pühringer, et al.
Pubblicazione: (2024-03-01)

Corrigendum to “Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1”
di: Manuel Pühringer, et al.
Pubblicazione: (2024-03-01)

Proteomic investigations of adult polyglucosan body disease: insights into the pathobiology of a neurodegenerative disorder
di: Joseph R. Abraham, et al.
Pubblicazione: (2023-11-01)

P158: The diagnostic odyssey: A review of two patients with adult polyglucosan body disease
di: Anusha Ebrahim, et al.
Pubblicazione: (2023-01-01)

A case of polyglucosan body myopathy caused by an RBCK1 gene variant and literature review
di: Qiqing Sun, et al.
Pubblicazione: (2024-04-01)

Spastic ataxia with sensory neuropathy sans cerebral leukodystrophy in probable adult polyglucosan body disease
di: Rohan Mahale, et al.
Pubblicazione: (2023-01-01)

PAS GRANULES AND WASTEOSOMES: ASTROCYTIC POLYGLUCOSAN AGGREGATES IN THE AGING BRAIN
di: Clara Romera, et al.
Pubblicazione: (2023-10-01)

Clinical and genetic heterogeneity of adult polyglucosan body disease caused by GBE1 biallelic mutations in China
di: Yikun Chen, et al.
Pubblicazione: (2024-09-01)

Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China
di: Lin Chen, et al.
Pubblicazione: (2021-01-01)

Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases
di: Mitchell A. Sullivan, et al.
Pubblicazione: (2019-04-01)

Case report: Expanding the understanding of the adult polyglucosan body disease continuum: novel presentations, diagnostic pitfalls, and clinical pearls
di: Matthew M. Gayed, et al.
Pubblicazione: (2023-12-01)

Spectrophotometric Enzyme Assays for High-Throughput Screening
di: Jean-Louis Reymond
Pubblicazione: (2004-01-01)

Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents
di: Md Abu Horaira, et al.
Pubblicazione: (2023-03-01)

A high-throughput screening approach to discovering good forms of inspired visual representation
di: Pinto, Nicolas, et al.
Pubblicazione: (2010)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
di: Zhenya Wang, et al.
Pubblicazione: (2023-03-01)

Enzyme assays : high-throughput screening, genetic selection and fingerprinting /
di: Reymond, Jean-Louis
Pubblicazione: (2006)

Apoptosis assessment in high-content and high-throughput screening assays
di: Céline Rens, et al.
Pubblicazione: (2021-06-01)

A High-Throughput Screening Approach to Discovering Good Forms of Biologically Inspired Visual Representation
di: Cox, David D., et al.
Pubblicazione: (2010)

Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
di: Christelle Cabrol, et al.
Pubblicazione: (2009-01-01)

A high-throughput screening approach to discovering good forms of biologically inspired visual representation.
di: Nicolas Pinto, et al.
Pubblicazione: (2009-11-01)

High-throughput screens using photo-highlighting discover BMP signaling in mitochondrial lipid oxidation
di: Yong Yu, et al.
Pubblicazione: (2017-10-01)

A medium-throughput protease assay for screening green plant material
di: Christina Stonoha-Arther, et al.
Pubblicazione: (2025-01-01)

Mining Chemical Activity Status from High-Throughput Screening Assays.
di: Othman Soufan, et al.
Pubblicazione: (2015-01-01)

A High-Throughput In Vitro Assay for Screening Rice Starch Digestibility
di: Michelle R. Toutounji, et al.
Pubblicazione: (2019-11-01)

An improved high-throughput screening assay for tunicamycin sensitivity in Arabidopsis seedlings
di: Maggie E McCormack, et al.
Pubblicazione: (2015-08-01)

An enzymatic assay for high-throughput screening of cytidine-producing microbial strains.
di: Huina Dong, et al.
Pubblicazione: (2015-01-01)

High-Throughput Chinmedomics Strategy Discovers the Quality Markers and Mechanisms of Wutou Decoction Therapeutic for Rheumatoid Arthritis
di: Taiping Li, et al.
Pubblicazione: (2022-04-01)

Candidate ferroelectrics via ab initio high-throughput screening of polar materials
di: Francesco Ricci, et al.
Pubblicazione: (2024-01-01)

Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds.
di: Jair L Siqueira-Neto, et al.
Pubblicazione: (2010-01-01)

High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis
di: Faris Alkhilaiwi, et al.
Pubblicazione: (2019-12-01)

High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
di: Olujide O. Olubiyi, et al.
Pubblicazione: (2020-07-01)

Experimentally validated novel inhibitors of Helicobacter pylori phosphopantetheine adenylyltransferase discovered by virtual high-throughput screening.
di: Chao-Sheng Cheng, et al.
Pubblicazione: (2013-01-01)

Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay.
di: Helton J Wiggers, et al.
Pubblicazione: (2013-01-01)

Discovering root causal genes with high-throughput perturbations
di: Eric V Strobl, et al.
Pubblicazione: (2025-03-01)